Cargando…
PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429450/ http://dx.doi.org/10.1097/01.HS9.0000975024.35238.f0 |
| _version_ | 1785090716317253632 |
|---|---|
| author | Kulasekararaj, Austin Mellor, Jennifer Earl, Lucy Wang, Alice Patel, Yogesh Myren, Karl-Johan Fuereder, Wolfgang Nagalla, Srikanth |
| author_facet | Kulasekararaj, Austin Mellor, Jennifer Earl, Lucy Wang, Alice Patel, Yogesh Myren, Karl-Johan Fuereder, Wolfgang Nagalla, Srikanth |
| author_sort | Kulasekararaj, Austin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294502023-08-17 PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION Kulasekararaj, Austin Mellor, Jennifer Earl, Lucy Wang, Alice Patel, Yogesh Myren, Karl-Johan Fuereder, Wolfgang Nagalla, Srikanth Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429450/ http://dx.doi.org/10.1097/01.HS9.0000975024.35238.f0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Kulasekararaj, Austin Mellor, Jennifer Earl, Lucy Wang, Alice Patel, Yogesh Myren, Karl-Johan Fuereder, Wolfgang Nagalla, Srikanth PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title | PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title_full | PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title_fullStr | PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title_full_unstemmed | PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title_short | PB2056: PREVALENCE OF CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS IN STABLE C5 INHIBITOR-TREATED PATIENTS WITH PNH AND ITS ASSOCIATION WITH DISEASE CONTROL, QUALITY OF LIFE AND TREATMENT SATISFACTION |
| title_sort | pb2056: prevalence of clinically significant extravascular hemolysis in stable c5 inhibitor-treated patients with pnh and its association with disease control, quality of life and treatment satisfaction |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429450/ http://dx.doi.org/10.1097/01.HS9.0000975024.35238.f0 |
| work_keys_str_mv | AT kulasekararajaustin pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT mellorjennifer pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT earllucy pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT wangalice pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT patelyogesh pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT myrenkarljohan pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT fuerederwolfgang pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction AT nagallasrikanth pb2056prevalenceofclinicallysignificantextravascularhemolysisinstablec5inhibitortreatedpatientswithpnhanditsassociationwithdiseasecontrolqualityoflifeandtreatmentsatisfaction |